GlassScriptPhysician profile
Estuardo A Ponce
NPI 1023213071
$2,973.70
in general payments reported to CMS, 2019-2025
16 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $145 · 2021: $289 · 2022: $326 · 2023: $371 · 2024: $531 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,068.41 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $677.66 | 2019-2025 | Vabysmo |
| Astellas Pharma US INC | $288.29 | 2023-2025 | Izervay |
| Harrow Eye, LLC | $220.75 | 2024-2025 | Iheezo |
| Eyepoint US, INC. | $125.98 | 2020 | |
| Abbvie INC. | $113.07 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $98.83 | 2019-2020 | |
| Allergan, INC. | $96.96 | 2019-2021 | |
| Shire North American Group INC | $66.50 | 2019 | |
| Amgen INC. | $62.25 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $56.67 | 2024-2025 | Xdemvy |
| Ani Pharmaceuticals, INC. | $25.12 | 2025 | Iluvien |
| Sun Pharmaceutical Industries INC. | $21.80 | 2019 | |
| Apellis Pharmaceuticals, INC. | $20.52 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.02 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $12.87 | 2023 | Eysuvis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Estuardo Ponce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.